Skip to main content
. Author manuscript; available in PMC: 2016 Jan 31.
Published in final edited form as: Schizophr Res. 2014 Dec 8;161(0):407–413. doi: 10.1016/j.schres.2014.10.043

Table 1.

Sample Characteristics at Study Entry for Recent-Onset Schizophrenia Patients

Sample 1 at Baseline (n=102) Sample 2 at Baseline (n=47) Difference Samples 1 and 2 Combined (n=149)

Mean Age (SD) 23.4 (4.4) 25.0 (5.3) F(1,148)=3.92 p=.05 23.7 (4.45)

Mean Education (SD) 12.4 (2.1) 13.5 (2.1) F(1,147)=8.2, p<.01 12.91 (2.2)

Gender 84 (82%) 33 (70%) χ2(1)=2.7, p=.10 117 (78%)

Marital Status χ2(3)=5.81, p=.181
 Single 93 (91%) 41 (87%) 134 (90%)
 Married 4 (4%) 4 (8%) 8 (5%)
 Divorced 1 (1) 2 (4%) 3 (2%)
 Separated 4 (4%) 0 4 (3%)

Race
 Caucasian 95 (93%) 23 (50%) χ2(3)=53.8, p<.01 118 (79%)
 Asian 3 (3%) 5 (11%) 8 (5%)
 Native American/Pacific Islander 0 0 0
 African American 0 13 (28%) 13 (9%)
 Other 4 (4%) 6 (13%) 10 (3%)

Diagnosis
 Schizophrenia 61 (59%) 35 (74%) χ2(3)=11.2, p<.01 95 (64%)
 Schizoaffective 8 (8%) 6 (13% 14 (10%)
 Schizophreniform 33 (33%) 5 (11%) 38 (26%)
 Other Psychotic Disorder 1 (2%) 1 (1%)

Number of months (mean, SD) since psychosis onset, including prodrome, at study entry 6.8 (7.1) 8.0 (6.8) F(1,143)=1.0, p=.32 9.08 (8.63)

Chlorpromazine equivalent dosage, mg (mean, SD) 137.4 (110.1) 275.6 (126.9) F(1,94)=23.4, p<.01 166.22 (126.38)